Increasing Aminoterminal-pro-B-type Natriuretic Peptide Precedes the Development of Arterial Hypertension: the Multiethnic Study of Atherosclerosis

Overview

Journal J Hypertens

Specialty Cardiology & Vascular Diseases

Date 2015 Apr 25

PMID 25909698

Citations 10

Authors

Otto A Sanchez

David R Jacobs Jr

Hossein Bahrami

Carmen A Peralta

Lori B Daniels

Joao A Lima

Alan Maisel

Daniel A Duprez

Affiliations

Soon will be listed here.

Abstract

Background: Longitudinal associations between the aminoterminal pro-B-type natriuretic peptide (NT-proBNP) and incident hypertension are lacking.

Methods: We tested associations between baseline NT-proBNP (bNT-proBNP) and change in NT-proBNP (ΔNT-proBNP) (visit 3 NT-proBNP - bNT-proBNP, 3.2 years apart) with incident hypertension (SBP ≥ 140 and/or DBP ≥90 mmHg or taking antihypertensive medications). Incident hypertension was evaluated in 5596 individuals in the Multi-Ethnic Study of Atherosclerosis without hypertension at baseline (53% women, age range 45-84 years without overt cardiovascular disease) and follow-up for 9.5 years and in a subgroup (1550) who had bNT-proBNP less than 100 pg/ml and no hypertension at visit 3. Incident hypertension was regressed (proportional hazards) on quintiles of bNT-proBNP (range) (reference <19.2, 19.3-40.8, 40.9-70.9, 71-135.2, and >135.5) and also on ΔNT-proBNP categories (reference <-10, -10 to 10, >10 to 50, and >50 pg/ml). Hazard ratios were adjusted for age, race, sex, education, diabetes, obesity, left ventricle mass/height, SBP and DBP, interleukin-6, salt intake, estimated glomerular filtration rate, and exercise.

Results: Compared with the reference category, hazard ratios (95% confidence interval) for incident hypertension compared with the first quintile of bNT-proBNP were 1.47 (1.13-1.93), 1.57 (1.18-2.09), 1.52 (1.12-2.06), and 2.36 (1.62-3.41). Hazard ratios for incident hypertension by categories of ΔNT-proBNP from 3.2 to 9.5 years follow-up were 0.98 (0.62-1.56), 1.13 (0.72-1.79), and 1.82 (1.07-3.12).

Conclusion: The development of hypertension tended to be preceded by elevated levels of bNT-proBNP or a substantial positive ΔNT-proBNP.

Citing Articles

Cardiac Biomarkers in a Brazilian Indigenous Population Exposed to Arboviruses: A Cross-Sectional Study.

Nicacio J, de Souza C, Gomes O, Souza B, Lima J, do Carmo R Viruses. 2025; 16(12.

PMID: 39772209 PMC: 11680384. DOI: 10.3390/v16121902.

The association between left ventricular mass index and serum sirtuin 3 level in patients with hypertension.

Karayigit O, Celik M, Kiziltunc E, Cicekcioglu H, Topcuoglu C, Doganay B Cardiovasc Endocrinol Metab. 2021; 10(2):99-105.

PMID: 34113795 PMC: 8186516. DOI: 10.1097/XCE.0000000000000231.

Cyclic guanosine monophosphate and 10-year change in left ventricular mass: the Multi-Ethnic Study of Atherosclerosis (MESA).

Subramanya V, Zhao D, Ouyang P, Ying W, Vaidya D, Ndumele C Biomarkers. 2021; 26(4):309-317.

PMID: 33715578 PMC: 8281442. DOI: 10.1080/1354750X.2021.1893811.

Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism.

Wu Q, Hong M, Xu J, Tang X, Zhu L, Gao P Endocrine. 2021; 72(3):835-843.

PMID: 33474712 DOI: 10.1007/s12020-021-02606-3.

The Sleep Apnea-Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality.

Azarbarzin A, Sands S, Younes M, Taranto-Montemurro L, Sofer T, Vena D Am J Respir Crit Care Med. 2021; 203(12):1546-1555.

PMID: 33406013 PMC: 8483223. DOI: 10.1164/rccm.202010-3900OC.

References

Newton-Cheh C, Larson M, Vasan R, Levy D, Bloch K, Surti A . Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet. 2009; 41(3):348-53. PMC: 2664511. DOI: 10.1038/ng.328. View

Betti I, Castelli G, Barchielli A, Beligni C, Boscherini V, De Luca L . The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail. 2009; 15(5):377-84. DOI: 10.1016/j.cardfail.2008.12.002. View

Jenny N, Brown E, Detrano R, Folsom A, Saad M, Shea S . Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2009; 209(1):226-9. PMC: 2830357. DOI: 10.1016/j.atherosclerosis.2009.08.037. View

Jensen J, Ma L, Fu M, Svaninger D, Lundberg P, Hammarsten O . Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio. Clin Res Cardiol. 2010; 99(7):445-52. DOI: 10.1007/s00392-010-0140-z. View

Paget V, Legedz L, Gaudebout N, Girerd N, Bricca G, Milon H . N-terminal pro-brain natriuretic peptide: a powerful predictor of mortality in hypertension. Hypertension. 2011; 57(4):702-9. DOI: 10.1161/HYPERTENSIONAHA.110.163550. View

Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M . Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A. 2000; 97(8):4239-44. PMC: 18212. DOI: 10.1073/pnas.070371497. View

Freitag M, Larson M, Levy D, Benjamin E, Wang T, Leip E . Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Hypertension. 2003; 41(4):978-83. DOI: 10.1161/01.HYP.0000061116.20490.8D. View

Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6):1206-52. DOI: 10.1161/01.HYP.0000107251.49515.c2. View

Xia W, Huang Y, Chen Y, Chen S, He J . Acute myocardial ischemia directly modulates the expression of brain natriuretic peptide at the transcriptional and translational levels via inflammatory cytokines. Eur J Pharmacol. 2011; 670(1):7-12. DOI: 10.1016/j.ejphar.2011.09.012. View

10.

Peralta C, Jacobs Jr D, Katz R, Ix J, Madero M, Duprez D . Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2011; 59(1):41-9. PMC: 3242889. DOI: 10.1053/j.ajkd.2011.08.015. View

11.

Cataliotti A, Costello-Boerrigter L, Chen H, Textor S, Burnett Jr J . Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension. Mayo Clin Proc. 2012; 87(4):413-5. PMC: 3497998. DOI: 10.1016/j.mayocp.2012.02.003. View

12.

Clerico A, Vittorini S, Passino C . Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance. Clin Chem Lab Med. 2011; 49(12):1949-54. DOI: 10.1515/CCLM.2011.686. View

13.

Clerico A, Vittorini S, Passino C . Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations. Adv Clin Chem. 2012; 58:31-44. DOI: 10.1016/b978-0-12-394383-5.00008-4. View

14.

Macheret F, Heublein D, Costello-Boerrigter L, Boerrigter G, Mckie P, Bellavia D . Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP. J Am Coll Cardiol. 2012; 60(16):1558-65. PMC: 4041520. DOI: 10.1016/j.jacc.2012.05.049. View

15.

Baerts L, Gomez N, Vanderheyden M, De Meester I, Mc Entee K . Possible mechanisms for brain natriuretic peptide resistance in heart failure with a focus on interspecies differences and canine BNP biology. Vet J. 2012; 194(1):34-9. DOI: 10.1016/j.tvjl.2012.06.019. View

16.

Fox E, Musani S, Singh P, Bidulescu A, Nagarajarao H, Samdarshi T . Association of plasma B-type natriuretic peptide concentrations with longitudinal blood pressure tracking in African Americans: findings from the Jackson Heart Study. Hypertension. 2012; 61(1):48-54. PMC: 3521855. DOI: 10.1161/HYPERTENSIONAHA.112.197657. View

17.

Eggers K, Venge P, Lind L . Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years. Am J Cardiol. 2012; 111(1):131-6. DOI: 10.1016/j.amjcard.2012.08.058. View

18.

Patton K, Heckbert S, Alonso A, Bahrami H, Lima J, Burke G . N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity. Heart. 2013; 99(24):1832-6. DOI: 10.1136/heartjnl-2013-304724. View

19.

Sanchez O, Duprez D, Bahrami H, Daniels L, Folsom A, Lima J . The associations between metabolic variables and NT-proBNP are blunted at pathological ranges: the Multi-Ethnic Study of Atherosclerosis. Metabolism. 2014; 63(4):475-83. PMC: 3965618. DOI: 10.1016/j.metabol.2013.11.017. View

20.

Grundy S, Brewer Jr H, Cleeman J, Smith Jr S, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3):433-8. DOI: 10.1161/01.CIR.0000111245.75752.C6. View